GlassScriptPhysician profile
Robert D Hoy
NPI 1124351655
$41,496.48
in general payments reported to CMS, 2019-2025
35 companies · $1,234 in 2025
The $1,234 reported for 2025 was more than what 86% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14K · 2022: $11K · 2023: $4,605 · 2024: $11K · 2025: $1,234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $10K · Food and Beverage: $3,664 · Travel and Lodging: $1,863 · Honoraria: $1,548 · Education: $39.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,035.00 |
| Food and Beverage | $3,663.83 |
| Travel and Lodging | $1,863.25 |
| Honoraria | $1,547.93 |
| Education | $39.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $29,735.77 | 2021-2025 | Erleada, Akeega |
| Dendreon Pharmaceuticals LLC | $6,645.27 | 2021-2025 | Provenge |
| Accord Healthcare, INC. | $1,606.53 | 2023-2024 | |
| Astellas Pharma US INC | $600.99 | 2021-2025 | Xtandi |
| Bayer Healthcare Pharmaceuticals INC. | $451.52 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $410.69 | 2023-2025 | Orgovyx, Gemtesa |
| Pfizer INC. | $359.00 | 2021-2025 | |
| Myovant Sciences INC. | $236.53 | 2021-2022 | |
| Tempus Ai, INC | $220.70 | 2024-2025 | Xt Cdx |
| Abbvie INC. | $103.63 | 2024-2025 | |
| Axonics, INC. | $98.03 | 2024 | Axonics |
| Amgen INC. | $95.67 | 2021-2023 | Prolia, Xgeva |
| Tolmar Pharmaceuticals, INC. | $91.65 | 2021-2022 | |
| Teleflex LLC | $67.32 | 2021-2024 | Urolift |
| Ferring Pharmaceuticals INC. | $66.59 | 2024 | Adstiladrin |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Calyxo, INC. | $58.94 | 2023 | Cvac Aspiration System |
| Novartis Pharmaceuticals Corporation | $58.83 | 2024-2025 | |
| Blue Earth Diagnostics | $57.76 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $57.13 | 2023-2024 | Pylarify |
| Sun Pharmaceutical Industries INC. | $56.71 | 2023 | Yonsa, Odomzo |
| Urogen Pharma, INC. | $56.10 | 2024 | |
| Tolmar, INC. | $55.97 | 2023 | |
| Allergan, INC. | $41.46 | 2021 | |
| Janssen Scientific Affairs, LLC | $35.04 | 2021 | |
| Verity Pharmaceuticals INC. | $30.50 | 2022-2023 | Trelstar |
| Medtronic, INC. | $29.61 | 2023 | Interstim |
| C. R. Bard, INC. & Subsidiaries | $23.07 | 2023 | Bard Urinary Drainage Bag |
| Astrazeneca Pharmaceuticals LP | $22.52 | 2021 | |
| Immunitybio, INC. | $22.14 | 2024 | |
| Myriad Genetic Laboratories, INC. | $20.79 | 2024 | Prolaris |
| Organon LLC | $20.20 | 2025 | |
| Merck Sharp & Dohme LLC | $16.64 | 2022 | |
| Coloplast Corp | $16.43 | 2024 | |
| Boston Scientific Corporation | $15.40 | 2024 | Advantage System |
| Convatec INC. | $11.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Hoy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.